DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Nauck MA, Meier JJ, Schmidt WE.
Incretin-based glucose-lowering medications and the risk of acute pancreatitis and/or pancreatic cancer: Reassuring data from cardio-vascular outcome trials.
Diabetes Obes Metab 2017;
19 (09) 1327-1328
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.